Showing Results for: “Covid-19”

Natalie has been living with type 1 diabetes since she was six years old and is based in NYC. She loves to travel in order to push herself outside of her comfort zone and has been to all seven continents and 50+ countries. During the COVID-19 pandemic Natalie has been salsa dancing, learning to knit, and writing to connect with others! On a morning in early November I woke up late, rushed to the subway, and couldn't see out of one eye. I thought it was a dirty contact and vowed to replace it later at work. One emergency eye appointment and one panic attack later I was told that my diabetic

At 7 years old, a time when homework tends to be the most significant responsibility in a child’s life, I was battling serious health issues. I was sick, extremely dehydrated, and consistently falling due to being lightheaded and dizzy. Finally, my doctor tested my blood sugar and I received a diagnosis of type 1 diabetes. I had to grow up faster than most kids as I learned more about my illness and how to manage it. Luckily, I had the support of my parents who were extremely hands on with my care. My mom helped me with all of my insulin shots and my dad joined the board of the JDRF. Outside

Roxanna, from Brownsville, Texas, shares the story of her diagnosis — and how it changed her life. My diabetes journey began in August 2016. I was 29 years old. Like many who are first diagnosed, I ended up in the hospital with high blood sugar, severe dehydration, fatigue and exhaustion. “If you were my sister,” I recall my doctor saying, “I’d send you to the hospital.” And off to the hospital I went. I remember that day like it was yesterday: the doctors, the nurses, the diabetes educator, the concerned look on my parents’ faces. I didn’t even know what diabetes was at the time, much less

Expanded results from the first-of-its-kind clinical trial explores the use of SGLT2 inhibitor for COVID-19 patients with hypertension, cardiovascular disease, heart failure, type 2 diabetes, or chronic kidney disease DARE-19 is the first large randomized clinical trial to assess sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with and without type 2 diabetes hospitalized with COVID-19. Additional findings from the trial were presented today at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Patients with cardiometabolic risk factors, including

Study shows diabetes patients not taking medication experienced longer hospitalization and recovery with greatest toll among Latinx populations A new study reveals unmanaged diabetes is a key factor in COVID-19 severity and complications, particularly among Hispanic and Latinx populations. Findings of the retrospective study were presented at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Forty percent of Americans who have died of COVID-19 have had diabetes, and 1 in 10 people with diabetes hospitalized for COVID-19 die within one week – making diabetes a

“With more than 40 percent of all COVID-19 related deaths occurring among people with diabetes, many if not all adults with the disease, should strongly consider getting vaccine boosters. We urge people with diabetes to consult with their health care providers to discuss if the booster is appropriate for them,” said Dr. Robert Gabbay, Chief Scientific and Medical Officer for the American Diabetes Association. # # # , About the American Diabetes Association Every day more than 4,000 people are newly diagnosed with diabetes in America. More than 122 million Americans have diabetes or prediabetes

The health and safety of those we serve continues to be the top priority of the American Diabetes Association (ADA). At this time, the World Health Organization (WHO) has made the assessment that COVID-19 can be characterized as a pandemic. We agree with The Centers for Disease Control and Prevention (CDC) that COVID-19 (coronavirus) is a serious public health threat—and older adults and people with serious chronic medical conditions, including diabetes, are at a higher risk of getting very sick from it. The CDC reports that people in places where ongoing community spread of the virus that

The ADA has resources for people with diabetes at diabetes.org/coronoavirus The CDC has determined that COVID-19 is a serious public health threat. In general people with diabetes face greater risks of complications when dealing with viral infections like flu, and that is likely to be true with COVID-19. Recommended safety precautions are the same as for flu, such as frequent hand washing and covering coughs and sneezes with a tissue. The CDC does not recommend the use of face masks by people who are not infected. The American Diabetes Association (ADA) encourages people with diabetes to

New study points to diabetes management as critical factor in improving patient outcomes during pandemic outbreaks Findings of a new study show diabetes was the main risk factor for the accelerated advancement to a severe state in Japanese COVID-19 patients. Results of the retrospective analysis were presented at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Throughout the pandemic, diabetes has persisted as a significant risk factor for COVID-19. In hospitalized patients with diabetes and COVID-19, one in 10 people die within seven days of admission

Last night Congress took an important step toward COVID-19 management and recovery, addressing health disparities and funding crucial diabetes research programs. The diabetes community has been disproportionately affected by this pandemic, and the American Diabetes Association® (ADA) is pleased that Americans with diabetes will soon see some relief during these difficult and extraordinary times. Although there’s still much more to be done to support those facing a heightened risk during this unprecedented public health and economic crisis – including ensuring continuity of health insurance